Wen‐Chi Wu

584 total citations
20 papers, 255 citations indexed

About

Wen‐Chi Wu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Wen‐Chi Wu has authored 20 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Wen‐Chi Wu's work include Respiratory and Cough-Related Research (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Wen‐Chi Wu is often cited by papers focused on Respiratory and Cough-Related Research (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Wen‐Chi Wu collaborates with scholars based in Taiwan, United States and United Kingdom. Wen‐Chi Wu's co-authors include Alyn H. Morice, Susannah Thackray-Nocera, Caroline Wright, Kayleigh Brindle, R. Thompson, Anthony Ford, Michael M. Kitt, Andrew M. Tershakovec, Jen-Wen Hung and Rheun‐Chuan Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

Wen‐Chi Wu

19 papers receiving 251 citations

Peers

Wen‐Chi Wu
David J. Brinkman Netherlands
F. Torresan Italy
E. Øster-Jørgensen Denmark
B Whitney United Kingdom
Amin A. Ramzan United States
A. C. Schloithe Australia
Katherine Griffin Canada
Caroline Minville Canada
Yuan‐Hong Jiang Taiwan
Heather C. Nardone United States
David J. Brinkman Netherlands
Wen‐Chi Wu
Citations per year, relative to Wen‐Chi Wu Wen‐Chi Wu (= 1×) peers David J. Brinkman

Countries citing papers authored by Wen‐Chi Wu

Since Specialization
Citations

This map shows the geographic impact of Wen‐Chi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Chi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Chi Wu more than expected).

Fields of papers citing papers by Wen‐Chi Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Chi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Chi Wu. The network helps show where Wen‐Chi Wu may publish in the future.

Co-authorship network of co-authors of Wen‐Chi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Chi Wu. A scholar is included among the top collaborators of Wen‐Chi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Chi Wu. Wen‐Chi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Wen‐Chi, et al.. (2024). Incorporating Tumor Genomic Profiling and Circulating Tumor Cell-derived Organoids into Clinical Practice for Gastrointestinal Cancers. Anticancer Research. 44(8). 3481–3491. 1 indexed citations
2.
3.
4.
McGarvey, Lorcan, Mandel Sher, Susan Lu, et al.. (2023). The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough. Lung. 201(2). 111–118. 21 indexed citations
5.
Wu, Wen‐Chi, Yi‐Ping Hung, Chien‐An Liu, et al.. (2022). Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience. Investigational New Drugs. 40(4). 789–797. 32 indexed citations
6.
Wu, Wen‐Chi, Chi‐Cheng Huang, Yi‐Fang Tsai, et al.. (2022). The association of trastuzumab with atrial fibrillation and heart failure in breast cancer patients in routine clinical practice: a population-based propensity score matching and competing risk model analysis. Breast Cancer Research and Treatment. 198(1). 113–122. 5 indexed citations
7.
8.
Wu, Wen‐Chi & Ming‐Huang Chen. (2022). Triad of Myasthenia Gravis, Myositis, and Myocarditis after Nivolumab Administration in a Patient with Cholangiocarcinoma. Journal of Cancer Research and Practice. 9(4). 153–155. 1 indexed citations
9.
Hung, Jen-Wen, Wen‐Chi Wu, Yi‐Yu Chen, Ya‐Ping Pong, & Ku‐Chou Chang. (2021). Predictors of Clinically Important Improvements in Motor Function and Daily Use of Affected Arm after a Botulinum Toxin A Injection in Patients with Chronic Stroke. Toxins. 14(1). 13–13. 6 indexed citations
10.
Liao, Jason J. Z., G. Frank Liu, & Wen‐Chi Wu. (2020). Dynamic RMST curves for survival analysis in clinical trials. BMC Medical Research Methodology. 20(1). 218–218. 12 indexed citations
11.
12.
Wu, Wen‐Chi & Hsien‐Tzung Liao. (2020). IgG4‐Related Orbital Pseudotumor. Arthritis & Rheumatology. 72(12). 2168–2168. 1 indexed citations
13.
Morice, Alyn H., Michael M. Kitt, Anthony Ford, et al.. (2019). The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study. European Respiratory Journal. 54(1). 1900439–1900439. 113 indexed citations
14.
Sher, Mandel, Surinder S. Birring, John A. Smith, et al.. (2019). Evaluation of Cough Triggers Among Responders and Non-Responders of Treatment with MK-7264, a P2X3 Receptor Antagonist. Journal of Allergy and Clinical Immunology. 143(2). AB216–AB216. 1 indexed citations
15.
Wu, Wen‐Chi, et al.. (2019). Impacts of Different Modes of Bariatric Surgery on Plasma Levels of Hepassocin in Patients with Diabetes Mellitus. SHILAP Revista de lepidopterología. 2(4). 24–24. 2 indexed citations
16.
Wu, Wen‐Chi, et al.. (2019). Effective Lenvatinib Treatment Complicated with Secondary Tracheocutaneous Fistula in Patients with Advanced Anaplastic Thyroid Carcinoma. SHILAP Revista de lepidopterología. 2(3). 22–22. 1 indexed citations
17.
18.
Smith, John A., Lorcan McGarvey, Alyn H. Morice, et al.. (2018). The effect of baseline factors on treatment response with MK-7264, a P2X3 antagonist, in refractory chronic cough.. PA811–PA811. 1 indexed citations
19.
Wu, Wen‐Chi, et al.. (2013). Group Constraint-Induced Movement Therapy for Children With Hemiplegic Cerebral Palsy: A Pilot Study. American Journal of Occupational Therapy. 67(2). 201–208. 14 indexed citations
20.
Sontag, Stephen J., Malcolm Robinson, Walter M. Roufail, et al.. (1997). Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi‐centre double‐blind study. Alimentary Pharmacology & Therapeutics. 11(2). 373–380. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David J. Brinkman Breakdown of academic impact, for papers by F. Torresan Breakdown of academic impact, for papers by E. Øster-Jørgensen Breakdown of academic impact, for papers by B Whitney Breakdown of academic impact, for papers by Amin A. Ramzan Breakdown of academic impact, for papers by A. C. Schloithe Breakdown of academic impact, for papers by Katherine Griffin Breakdown of academic impact, for papers by Caroline Minville Breakdown of academic impact, for papers by Yuan‐Hong Jiang Breakdown of academic impact, for papers by Heather C. Nardone
Rankless by CCL
2026